Human relevance framework for rodent liver tumors induced by the insecticide sulfoxaflor

References

• Boobis AR, Cohen SM, Dellarco V, McGregor D, Meek ME, Vickers C, et al. (2006). IPCS framework for analyzing the relevance of a cancer mode of action for humans. Crit Rev Toxicol, 36, 781–92.
   PubMed Web of Science ®Google Scholar
• Boobis AR, Doe JE, Heinrich-Hirsch B, Meek ME, Munn S, Ruchirawat M, et al. (2008). IPCS framework for analyzing the relevance of a noncancer mode of action for humans. Crit Rev Toxicol, 38, 87–96.
   PubMed Web of Science ®Google Scholar
• Bursch W, Chabicovsky M, Wastl U, Grasl-Kraupp B, Bukowska K, Taper H, et al. (2005). Apoptosis in stages of mouse hepatocarcinogenesis: failure to counterbalance cell proliferation and to account for strain differences in tumor susceptibility. Toxicol Sci, 85, 515–29.
   PubMed Web of Science ®Google Scholar
• Cohen SM. (2010). Evaluation of possible carcinogenic risk to humans based on liver tumors in rodent assays: the two-year bioassay is no longer necessary. Toxicol Pathol, 38, 487–501.
   PubMed Web of Science ®Google Scholar
• Cohen SM, Meek ME, Klaunig JE, Patton DE, Fenner-Crisp PA. (2003). The human relevance of information on carcinogenic modes of action: overview. Crit Rev Toxicol, 33, 581–9.
   PubMed Web of Science ®Google Scholar
• ECHA. (2013). European Chemicals Agency. Risk Assessment Committee conclusion. http://www.echa.europa.eu/view-article/-/journal_content/title/rac-concludes-on-nine-scientific-opinions-for-clh. Accessed 10 March 2014.
   Google Scholar
• Elcombe CR, Peffer RC, Wolf DC, Bailey J, Bars R, Bell D, et al. (2014). Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: a case study with phenobarbital as a model constitutive androstane receptor (CAR) activator. Crit Rev Toxicol, 44, 64–82.
   PubMed Web of Science ®Google Scholar
• Ellis-Hutchings RG, Rasoulpour RJ, Terry C, Carney EW, Billington R. (2014). Human relevance framework evaluation of a novel rat developmental toxicity mode of action induced by sulfoxaflor. Crit Rev Toxicol, 44, 45–62.
   Google Scholar
• Endo A, Tsujita Y, Kuroda M, Tanzawa K. (1979). Effects of ML-236B on cholesterol metabolism in mice and rats: lack of hypocholesterolemic activity in normal animals. Biochim Biophys Acta, 575, 266–76.
   PubMed Web of Science ®Google Scholar
• EU. (2012). European Union Programme for Approval of Active Substances for inclusion to Regulation (EC) No 1107/2009 of the European Parliament and of the Council: Draft Assessment Report (DAR) for Sulfoxaflor. Volume 3 – Annex B.6, 2012.
   Google Scholar
• Farwell WR, Scranton RE, Lawler EV, Lew RA, Brophy MT, Fiore LD, Gaziano JM. (2008). The association between statins and cancer incidence in a veterans population. J Natl Cancer Inst, 100, 134–9.
   PubMed Web of Science ®Google Scholar
• Goldsworthy TL, Fransson-Steen R. (2002). Quantitation of the cancer process in C57BL/6J, B6C3F1 and C3H/HeJ mice. Toxicol Pathol, 30, 97–105.
   PubMed Web of Science ®Google Scholar
• Holsapple MP, Pitot HC, Cohen SM, Boobis AR, Klaunig JE, Pastoor T, et al. (2006). Mode of action in relevance of rodent liver tumors to human cancer risk. Toxicol Sci, 89, 51–6.
   PubMed Web of Science ®Google Scholar
• Huang W, Zhang J, Washington M, Liu J, Parant JM, Lozano G, Moore DD. (2005). Xenobiotic stress induces hepatomegaly and liver tumors via the nuclear receptor constitutive androstane receptor. Mol Endocrinol, 19, 1646–53.
   PubMed Web of Science ®Google Scholar
• JMPR. (2011). Joint FAO/WHO Meeting on Pesticide Residues. Sulfoxaflor Monograph. Geneva, 20–29 September 2011.
   Google Scholar
• Klaunig JE. (1993). Selective induction of DNA synthesis in mouse preneoplastic and neoplastic hepatic lesions after exposure to phenobarbital. Environ Health Perspect, 101, 235–9.
   PubMed Web of Science ®Google Scholar
• Klaunig JE, Hocevar BA, Kamendulis LM. (2012). Mode of action analysis of perfluorooctanoic acid (PFOA) tumorigenicity and human relevance. Reprod Toxicol, 33, 410–8.
   PubMed Web of Science ®Google Scholar
• Kocarek TA, Reddy AB. (1996). Regulation of cytochrome P450 expression by inhibitors of hydroxymethylglutaryl-coenzyme A reductase in primary cultured rat hepatocytes and in rat liver. Drug Metab Dispos, 24, 1197–204.
   PubMed Web of Science ®Google Scholar
• Kolaja KL, Stevenson DE, Johnson JT, Walborg EF Jr, Klaunig JE. (1996a). Subchronic effects of dieldrin and phenobarbital on hepatic DNA synthesis in mice and rats. Fundam Appl Toxicol, 29, 219–28.
   PubMedGoogle Scholar
• Kolaja KL, Stevenson DE, Walborg EF Jr, Klaunig JE. (1996b). Dose dependence of phenobarbital promotion of preneoplastic hepatic lesions in F344 rats and B6C3F1 mice: effects on DNA synthesis and apoptosis. Carcinogenesis, 17, 947–54.
   PubMed Web of Science ®Google Scholar
• Lake BG. (2009). Species differences in the hepatic effects of inducers of CYP2B and CYP4A subfamily forms: relationship to rodent liver tumour formation. Xenobiotica, 39, 582–96.
   PubMed Web of Science ®Google Scholar
• Lambert CB, Spire C, Claude N, Guillouzo A. (2009). Dose- and time-dependent effects of phenobarbital on gene expression profiling in human hepatoma HepaRG cells. Toxicol Appl Pharmacol, 234, 345–60.
   PubMed Web of Science ®Google Scholar
• Lamminpaa A, Pukkala E, Teppo L, Neuvonen PJ. (2002). Cancer incidence among patients using antiepileptic drugs: a long-term follow-up of 28,000 patients. Eur J Clin Pharmacol, 58, 137–41.
   PubMed Web of Science ®Google Scholar
• LeBaron MJ, Geter DR, Rasoulpour RJ, Gollapudi BB, Thomas J, Murray J, et al. (2013). An integrated approach for prospectively investigating a mode-of-action for rodent liver effects. Toxicol Appl Pharmacol, 270, 164–73.
   PubMed Web of Science ®Google Scholar
• MacDonald JS, Halleck MM. (2004). The toxicology of HMG-CoA reductase inhibitors: prediction of human risk. Toxicol Pathol, 32, 26–41.
   PubMedGoogle Scholar
• MacDonald JS, Gerson RJ, Kornbrust DJ, Kloss MW, Prahalada S, Berry PH, et al. (1988). Preclinical evaluation of lovastatin. Am J Cardiol, 62, 16J–27J.
   PubMed Web of Science ®Google Scholar
• Meek ME, Bucher JR, Cohen SM, Dellarco V, Hill RN, Lehman-Mckeeman LD, et al. (2003). A framework for human relevance analysis of information on carcinogenic modes of action. Crit Rev Toxicol, 33, 591–653.
   PubMed Web of Science ®Google Scholar
• Rasoulpour RJ, Terry C, LeBaron MJ, Stebbins K, Ellis-Hutchings RG, Billington R. (2014). Mode-of-action/human relevance framework for rat Leydig cell tumors mediated by sulfoxaflor. Crit Rev Toxicol, 44, 25–44.
   Google Scholar
• Rencurel F, Foretz M, Kaufmann MR, Stroka D, Looser R, Leclerc I, et al. (2006). Stimulation of AMP-activated protein kinase is essential for the induction of drug metabolizing enzymes by phenobarbital in human and mouse liver. Mol Pharmacol, 70, 1925–34.
   PubMed Web of Science ®Google Scholar
• Schulte-Hermann R, Kraupp-Grasl B, Bursch W, Gerbracht U, Timmermann-Trosiener I. (1989). Effects of non-genotoxic hepatocarcinogens phenobarbital and nafenopin on phenotype and growth of different populations of altered foci in rat liver. Toxicol Pathol, 17, 642–9; discussion 649–50.
   PubMedGoogle Scholar
• Schulte-Hermann R, Timmermann-Trosiener I, Barthel G, Bursch W. (1990). DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion. Cancer Res, 50, 5127–35.
   PubMed Web of Science ®Google Scholar
• Seed J, Carney EW, Corley RA, Crofton KM, DeSesso JM, Foster PM, et al. (2005). Overview: using mode of action and life stage information to evaluate the human relevance of animal toxicity data. Crit Rev Toxicol, 35, 664–72.
   PubMed Web of Science ®Google Scholar
• Sonich-Mullin C, Fielder R, Wiltse J, Baetcke K, Dempsey J, Fenner-Crisp P, et al. (2001). IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis. Regul Toxicol Pharmacol, 34, 146–52.
   PubMed Web of Science ®Google Scholar
• Terry C, Rasoulpour RJ, Saghir S, Marty MS, Gollapudi BB, Billington R. (2014). Application of a novel integrated toxicity testing strategy incorporating “3R” principles of animal research to evaluate the safety of a new agrochemical, sulfoxaflor. Crit Rev Toxicol, 44, 1–14.
   Google Scholar
• Ueda A, Hamadeh HK, Webb HK, Yamamoto Y, Sueyoshi T, Afshari CA, et al. (2002). Diverse roles of the nuclear orphan receptor CAR in regulating hepatic genes in response to phenobarbital. Mol Pharmacol, 61, 1–6.
   PubMed Web of Science ®Google Scholar
• USEPA. (2012). Human Health Risk Review and Carcinogenicity Assessment Review Committee (CARC) memo (published for public commenting January 2013, DR D2-382604).
   Google Scholar
• USEPA. (2005). Guidelines for Carcinogen Risk Assessment. In: AGENCY, U. E. P. (ed.).
   Google Scholar
• Watson GB, Loso MR, Babcock JM, Hasler JM, Letherer TJ, Young CD, et al. (2011). Novel nicotinic action of the sulfoximine insecticide sulfoxaflor. Insect Biochem Mol Biol, 41, 432–9.
   PubMed Web of Science ®Google Scholar
• Whysner J, Ross PM, Williams GM. (1996). Phenobarbital mechanistic data and risk assessment: enzyme induction, enhanced cell proliferation, and tumor promotion. Pharmacol Ther, 71, 153–91.
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Moore R, Goldsworthy TL, Negishi M, Maronpot RR. (2004). The orphan nuclear receptor constitutive active/androstane receptor is essential for liver tumor promotion by phenobarbital in mice. Cancer Res, 64, 7197–200.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Loso MR, Watson GB, Sparks TC, Rogers RB, Huang JX, et al. (2011). Discovery and characterization of sulfoxaflor, a novel insecticide targeting sap-feeding pests. J Agric Food Chem, 59, 2950–7.
   PubMed Web of Science ®Google Scholar